Janus Henderson Group PLC lowered its holdings in shares of HCP, Inc. (NYSE:HCP) by 6.7% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 3,973,530 shares of the real estate investment trust’s stock after selling 287,330 shares during the period. Janus Henderson Group PLC’s holdings in HCP were worth $127,060,000 as of its most recent filing with the SEC.
Several other institutional investors have also bought and sold shares of the company. BlackRock Inc. raised its holdings in shares of HCP by 1.3% during the 1st quarter. BlackRock Inc. now owns 46,737,345 shares of the real estate investment trust’s stock worth $1,462,881,000 after buying an additional 591,173 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in shares of HCP by 5.4% during the 1st quarter. JPMorgan Chase & Co. now owns 11,420,161 shares of the real estate investment trust’s stock worth $357,451,000 after buying an additional 581,291 shares in the last quarter. Resolution Capital Ltd raised its holdings in shares of HCP by 18.9% during the 2nd quarter. Resolution Capital Ltd now owns 8,757,892 shares of the real estate investment trust’s stock worth $280,077,000 after buying an additional 1,393,502 shares in the last quarter. Northern Trust Corp raised its holdings in shares of HCP by 8.8% during the 1st quarter. Northern Trust Corp now owns 8,540,565 shares of the real estate investment trust’s stock worth $267,320,000 after buying an additional 688,358 shares in the last quarter. Finally, Geode Capital Management LLC raised its holdings in shares of HCP by 11.8% during the 4th quarter. Geode Capital Management LLC now owns 7,752,843 shares of the real estate investment trust’s stock worth $216,236,000 after buying an additional 821,285 shares in the last quarter. 93.88% of the stock is owned by institutional investors.
A number of equities analysts have issued reports on the company. Stifel Nicolaus upped their target price on HCP from $32.00 to $34.00 and gave the stock a “buy” rating in a report on Thursday, August 1st. TheStreet raised HCP from a “c+” rating to a “b-” rating in a report on Friday, August 2nd. Raymond James raised HCP from a “market perform” rating to an “outperform” rating and set a $35.00 target price for the company in a report on Thursday, June 13th. Finally, KeyCorp upped their target price on HCP from $32.00 to $34.00 and gave the stock an “overweight” rating in a report on Monday, July 1st. Three equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. HCP has an average rating of “Buy” and a consensus price target of $32.25.
HCP (NYSE:HCP) last issued its earnings results on Wednesday, July 31st. The real estate investment trust reported ($0.03) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.46). HCP had a return on equity of 15.54% and a net margin of 53.57%. The firm had revenue of $489.15 million during the quarter, compared to analyst estimates of $444.67 million. During the same period in the previous year, the company earned $0.45 EPS. HCP’s revenue for the quarter was up 4.5% on a year-over-year basis. As a group, equities analysts forecast that HCP, Inc. will post 1.75 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, August 20th. Shareholders of record on Monday, August 5th will be given a $0.37 dividend. The ex-dividend date of this dividend is Friday, August 2nd. This represents a $1.48 dividend on an annualized basis and a dividend yield of 4.42%. HCP’s dividend payout ratio (DPR) is presently 81.32%.
HCP Company Profile
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Featured Article: When is a capital gain realized?
Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.